Micaela Montanari
Overview
Explore the profile of Micaela Montanari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
420
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Montanari M, Carbone M, Coppola L, Giuliano M, Arpino G, Lauria R, et al.
Mol Cancer Res
. 2018 Sep;
17(2):628-641.
PMID: 30242055
The surface glycoprotein THY is a marker of myoepithelial precursor cells, which are basal cells with epithelial-mesenchymal intermediate phenotype originating from the ectoderm. Myoepithelial precursor cells are lost during progression...
2.
Facchini G, Rossetti S, Cavaliere C, DAniello C, Di Franco R, Iovane G, et al.
Oncotarget
. 2018 Feb;
9(1):1365-1379.
PMID: 29416701
Testicular germ cell tumors (TGCTs) represent the most common solid tumors affecting young men. They constitute a distinct entity because of their embryonic origin and their unique biological behavior. Recent...
3.
Quagliariello V, Rossetti S, Cavaliere C, Di Palo R, Lamantia E, Castaldo L, et al.
Oncotarget
. 2017 Oct;
8(37):62816.
PMID: 28977991
[This corrects the article DOI: 10.18632/oncotarget.16725.].
4.
Botti G, Malzone M, La Mantia E, Montanari M, Vanacore D, Rossetti S, et al.
Int J Med Sci
. 2017 Jun;
14(6):554-559.
PMID: 28638271
The gold standard for the detection of urothelial carcinoma is represented by urethro-cystoscopy and biopsy. Both procedures are invasive and expensive and therefore cytology is often used as first approach...
5.
Vanacore D, Boccellino M, Rossetti S, Cavaliere C, DAniello C, Di Franco R, et al.
Oncotarget
. 2017 Apr;
8(30):50240-50251.
PMID: 28445135
Prostate cancer is the second highest cause of cancer mortality after lung tumours. In USA it affects about 2.8 million men and the incidence increases with age in many countries....
6.
Montanari M, Rossetti S, Cavaliere C, DAniello C, Malzone M, Vanacore D, et al.
Oncotarget
. 2017 Apr;
8(21):35376-35389.
PMID: 28430640
Prostate cancer is a main urological disease associated with significant morbidity and mortality. Radical prostatectomy and radiotherapy are potentially curative for localized prostate cancer, while androgen deprivation therapy is the...
7.
Quagliariello V, Rossetti S, Cavaliere C, Di Palo R, Lamantia E, Castaldo L, et al.
Oncotarget
. 2017 Apr;
8(18):30606-30616.
PMID: 28389628
This review summarizes the main pathophysiological basis of the relationship between metabolic syndrome, endocrine disruptor exposure and prostate cancer that is the most common cancer among men in industrialized countries....
8.
Romano F, Rossetti S, Conteduca V, Schepisi G, Cavaliere C, Di Franco R, et al.
Oncotarget
. 2016 Nov;
7(51):85641-85649.
PMID: 27821802
Notwithstanding the peculiar sensitivity to cisplatin-based treatment, resulting in a very high percentage of cures even in advanced stages of the disease, still we do not know the biological mechanisms...
9.
Macaluso M, Caracciolo V, Rizzo V, Sun A, Montanari M, Russo G, et al.
Cell Cycle
. 2012 May;
11(9):1841-50.
PMID: 22544282
Distinct molecular pathways could be constitutively active in mouse T-Antigen positive and T-Antigen negative medulloblastoma cell lines, contributing to their phenotypic differences as well as to cellular responses, cell cycle...
10.
Fiorentino F, Macaluso M, Miranda F, Montanari M, Russo A, Bagella L, et al.
Mol Cancer Res
. 2011 Feb;
9(2):225-33.
PMID: 21325284
Although innumerable investigations regarding the biology of lung cancer have been carried out, many aspects thereof remain to be addressed, including the role played by the retinoblastoma-related protein Rb2/p130 during...